rethinkMushrooms Search
Menu
Research citation

Recalls, Availability, and Content of Dietary Supplements Following FDA Warning Letters.

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Recalls, Availability, and Content of Dietary Supplements Following FDA Warning Letters.

JAMA, 328(4), 393-395

Citation

Cohen, Pieter A; Avula, Bharathi; Katragunta, Kumar; Khan, Ikhlas. (2022). Recalls, Availability, and Content of Dietary Supplements Following FDA Warning Letters.. JAMA, 328(4), 393-395. https://doi.org/10.1001/jama.2022.9734